Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,933-1,944 of 4,306
Other study type icon
CompletedNCT01214135

Use of Seroquel Extended Release (XR) and Immediate Release (IR) for schizophrenia

This study is completed in Sweden. It is testing Use of Seroquel Extended Release (XR) and Immediate Release (IR) for schizophrenia.

Multiple locations, including Falköping
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Sweden
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT01150448

A Safety and Pharmacokinetic Study of Paliperidone Palmitate in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Belgium, Croatia, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT00119756

Safety study of paliperidone Palmitate Injected in schizophrenia

This study is completed. It is testing paliperidone Palmitate Injected for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03565068

Safety study of MK-8189 in schizophrenia

This study is completed in the United States. It is testing MK-8189 for schizophrenia.

In Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT02205099

Safety study of Multiple Oral Doses of SKL15508 in schizophrenia

This study is completed in the United States. It is testing Multiple Oral Doses of SKL15508 for schizophrenia.

In Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
SK Life Science, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01942161

A Short Treatment Study of Aripiprazole in Pediatric people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chubu Region
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT00649844

A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs

This study is completed in Italy. It focuses on schizophrenia.

Multiple locations, including Città di Castello
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Italy
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.